DOWDELL, SARAH E.,EIDAM, HILARY SCHENCK,ELBAN, MARK,FOX, RYAN MICHAEL,HAMMOND, MARLYS,HILFIKER, MARK A.,HOANG, TRAM H.,KALLANDER, LARA S.,LAWHORN, BRIAN GRIFFIN,MANNS, SHARADA,PHILP, JOANNE,WASHBURN,
申请号：
SG11201605539S
公开号：
SG11201605539SA
申请日:
2015.01.09
申请国别(地区):
SG
年份:
2016
代理人:
摘要：
wherein R1, R2 and R3 are as defined herein, and methods of making and using the same, including use as inhibitors of BMP1, TLL1 and/or TLL2 and in treatment of diseases associated with BMP1, TLL1 and/or TLL2 activity.
